0001400118-19-000002.txt : 20190225 0001400118-19-000002.hdr.sgml : 20190225 20190225171115 ACCESSION NUMBER: 0001400118-19-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190225 DATE AS OF CHANGE: 20190225 EFFECTIVENESS DATE: 20190225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: 3-V Biosciences, Inc. CENTRAL INDEX KEY: 0001400118 IRS NUMBER: 205991472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-333505 FILM NUMBER: 19630470 BUSINESS ADDRESS: STREET 1: 1999 S. BASCOM AVE., SUITE 700 CITY: CAMPBELL STATE: CA ZIP: 95008 BUSINESS PHONE: (650) 561-8600 MAIL ADDRESS: STREET 1: 1999 S. BASCOM AVE., SUITE 700 CITY: CAMPBELL STATE: CA ZIP: 95008 D 1 primary_doc.xml X0708 D LIVE 0001400118 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 (650) 561-8600 DELAWARE None None Corporation true George Kemble 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Executive Officer Director Merdad Parsey 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director Beth Seidenberg 3-V Biosciences, Inc., 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director Gordon Ringold 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director Jason Fuller 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director David Mott 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director James Young 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director Richard Rodgers 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director Jinzi Jason Wu 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director Xufang Duan 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Director Dennis Hom 3-V Biosciences, Inc. 1999 S. Bascom Ave., Suite 700 Campbell CA CALIFORNIA 95008 Executive Officer Biotechnology Decline to Disclose 06b false 2019-02-12 false true false 0 42197382 35204858 6992524 The total amount sold includes $20,224,082.12 in principal and interest from convertible promissory notes that was converted to Series E Preferred Stock. false 19 0 0 0 General corporate purposes. false 3-V Biosciences, Inc. /s/George Kemble George Kemble Chief Executive Officer 2019-02-21